IMMUNITYBIO, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $35.9M | $182.0M | $16.8M |
| FY2019 | $22.4M | $143.1M | $75.8M |
| FY2020 | $339.9M | $221.4M | $34.9M |
| FY2021 | $712.8M | $468.9M | $181.1M |
| FY2022 | $812.2M | $362.4M | $104.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $35.9M | $182.0M | $16.8M |
| FY2019 | $22.4M | $143.1M | $75.8M |
| FY2020 | $339.9M | $221.4M | $34.9M |
| FY2021 | $712.8M | $468.9M | $181.1M |
| FY2022 | $812.2M | $362.4M | $104.6M |